SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

Gotta agree Iggy --- the short cabal has

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
scottmiyadi Member Profile
 
Followed By 0
Posts 36
Boards Moderated 1
Alias Born 12/05/11
160x600 placeholder
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference "Business Wire" - 9/18/2017 9:02:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/11/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 4:07:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:33:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:32:40 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:02:24 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/12/2017 5:31:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/7/2017 6:04:08 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:33:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:24 PM
Advaxis’ Axalimogene Filolisbac Data Selected for Poster Presentation at ESGO 2017 "Business Wire" - 6/26/2017 8:55:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:32:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Advaxis to Present at 2017 BIO International Convention "Business Wire" - 6/16/2017 8:00:00 AM
Advaxis to Be Featured on Worldwide Business with kathy ireland® "Business Wire" - 6/14/2017 8:00:00 AM
Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day "Business Wire" - 6/13/2017 12:30:00 PM
Advaxis to Webcast Investor & Analyst Day 2017 "Business Wire" - 6/9/2017 8:00:00 AM
Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare Conference Now Available "Business Wire" - 6/8/2017 9:17:00 AM
Advaxis to Present at Jefferies 2017 Global Healthcare Conference "Business Wire" - 6/7/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 6/6/2017 5:34:23 PM
scottmiyadi   Wednesday, 09/13/17 07:01:29 PM
Re: ignatiusrielly35 post# 33766
Post # of 35480 
Gotta agree Iggy --- the short cabal has succeeded in lowering the base price level from which they can begin squaring up their large, accumulated short position. Just for argument's sake, consider that prior to this summer's early selloff the effective trading range was roughly $8-$11ish. Maybe to square up their short position would have required $20-$30ish price trading range. Now it's maybe $5-$12ish give or take? They no longer need further dilution to maximize their profits, their strategy has succeeded beyond what any of us would like but there it is. Hopefully they can now declare victory --- COVER ---so we can all move on. All IMHO assuming our science in the end is sound and management can eventually get the market to refocus on the science.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist